NGS and Germline Testing in Pancreatic Cancer

Opinion
Video

Panelists discuss how next-generation sequencing (NGS) and germline testing are increasingly being used in pancreatic cancer to identify genetic mutations, guide personalized treatment decisions, and inform the use of targeted therapies, ultimately improving patient outcomes and advancing precision medicine.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Related Content